A Case of Lung Abscesses Secondary to Mucormycosis in a Diabetic Female Patient
Lung Abscesses Secondary to Mucormycosis
DOI:
https://doi.org/10.54393/pbmj.v6i07.904Keywords:
fungal infections, tuberculosis, bronchoscopyAbstract
Mucormycosis is a rapidly advancing and hazardous form of opportunistic infection usually starts in nose and/or paranasal sinuses after inhaling fungal spores. This infection is caused by Mucorales fungi which belong to the Zygomycetes class. The incidence of Mucormycosis is approximately 1.7 cases in 1 million. They more frequently exist in rhinomaxillary area and is a rare pulmonary disease of an opportunistic fungi, which is difficult to diagnose with an unpredictable response to treatment. They usually appear in individuals with immunocompromised states such as diabetes, long term use of corticosteroids, immunosuppressive therapy for solid organ and hematopoietic cell transplantation, and disorders like neutropenia are notably common risk factors. As a potential for relatively life-threatening condition, the disorders warrant an anticipatory approach. We report here a case of pulmonary mucormycosis in uncontrolled diabetes presented with bilateral cavitary lesions in lungs that was first misdiagnosed as case of Pulmonary TB, later diagnosis was made on the basis of results of bronchoscopic biopsy, and was started on amphotericin and followed up with improvement of her symptoms.
References
Pennell E, Pecson I, Nakamura C, Galvis AE. Pulmonary mucormycosis in an adolescent female with type 1 diabetes mellitus. IDCases. 2018 Jan; 14: e00474. doi: 10.1016/j.idcr.2018.e00474. DOI: https://doi.org/10.1016/j.idcr.2018.e00474
Serris A, Danion F, Lanternier F. Disease entities in mucormycosis. Journal of Fungi. 2019 Mar; 5(1): 23. doi: 10.3390/jof5010023. DOI: https://doi.org/10.3390/jof5010023
Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clinical Microbiology Reviews. 2005 Jul; 18(3): 556-69. doi: 10.1128/CMR.18.3.556-569.2005. DOI: https://doi.org/10.1128/CMR.18.3.556-569.2005
Mohammadi A, Mehdizadeh A, Ghasemi-Rad M, Habibpour H, Esmaeli A. Pulmonary mucormycosis in patients with diabetic ketoacidosis: a case report and review of literature. Tuberk Toraks. 2012 Jan; 60(1): 66-9. doi: 10.5578/tt.2464. DOI: https://doi.org/10.5578/tt.2464
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clinical Infectious Diseases. 2005 Sep; 41(5): 634-53. doi: 10.1086/432579. DOI: https://doi.org/10.1086/432579
Kim Y, Lee KS, Jung KJ, Han J, Kim JS, Suh JS. Halo sign on high resolution CT: findings in spectrum of pulmonary diseases with pathologic correlation. Journal of Computer Assisted Tomography. 1999 Jul; 23(4): 622-6. doi: 10.1097/00004728-199907000-00025. DOI: https://doi.org/10.1097/00004728-199907000-00025
Donado-Uña JR, Díaz-Hellín V, López-Encuentra A, Echave-Sustaeta JM. Persistent cavitations in pulmonary mucormycosis after apparently successful amphotericin B. European Journal of Cardio-Thoracic Surgery. 2002 May; 21(5): 940-2. doi: 10.1016/S1010-7940(02)00081-7. DOI: https://doi.org/10.1016/S1010-7940(02)00081-7
Wang XM, Guo LC, Xue SL, Chen YB. Pulmonary mucormycosis: a case report and review of the literature. Oncology Letters. 2016 May; 11(5): 3049-53. doi: 10.3892/ol.2016.4370. DOI: https://doi.org/10.3892/ol.2016.4370
Chung JH, Godwin JD, Chien JW, Pipavath SJ. Case 160: pulmonary mucormycosis. Radiology. 2010 Aug; 256(2): 667-70. doi: 10.1148/radiol.10081907. DOI: https://doi.org/10.1148/radiol.10081907
Guarner J and Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clinical Microbiology Reviews. 2011 Apr; 24(2): 247-80. doi: 10.1128/CMR.00053-10. DOI: https://doi.org/10.1128/CMR.00053-10
Garg R, Marak RS, Verma SK, Singh J, Prasad R. Pulmonary mucormycosis mimicking as pulmonary tuberculosis: a case report. Lung India: Official Organ of Indian Chest Society. 2008 Jul; 25(3): 129. doi: 10.4103/0970-2113.59595. DOI: https://doi.org/10.4103/0970-2113.59595
Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Archives of Internal Medicine. 1999 Jun; 159(12): 1301-9. doi: 10.1001/archinte.159.12.1301. DOI: https://doi.org/10.1001/archinte.159.12.1301
Song JG, Kang SH, Jung BW, Oh HS, Kim MJ, Lee SH. Invasive pulmonary aspergillosis histologically mimicking mucormycosis. The Ewha Medical Journal. 2016 Apr; 39(2): 65-8. doi: 10.12771/emj.2016.39.2.65. DOI: https://doi.org/10.12771/emj.2016.39.2.65
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet infectious diseases. 2019 Dec; 19(12): e405-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com
